Verinurad structure
|
Common Name | Verinurad | ||
---|---|---|---|---|
CAS Number | 1352792-74-5 | Molecular Weight | 348.418 | |
Density | 1.3±0.1 g/cm3 | Boiling Point | 566.7±50.0 °C at 760 mmHg | |
Molecular Formula | C20H16N2O2S | Melting Point | N/A | |
MSDS | N/A | Flash Point | 296.5±30.1 °C |
Use of VerinuradVerinurad (RDEA3170) is a highly potent and specific URAT1 inhibitor with an IC50 of 25 nM[1]. |
Name | Verinurad |
---|---|
Synonym | More Synonyms |
Description | Verinurad (RDEA3170) is a highly potent and specific URAT1 inhibitor with an IC50 of 25 nM[1]. |
---|---|
Related Catalog | |
Target |
IC50: 25 nM (URAT1)[1] |
In Vitro | Verinurad inhibits the transport activity of human URAT1 in a dose-dependent manner, at high potency with an IC50 of 25 nM [1]. |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 566.7±50.0 °C at 760 mmHg |
Molecular Formula | C20H16N2O2S |
Molecular Weight | 348.418 |
Flash Point | 296.5±30.1 °C |
Exact Mass | 348.093262 |
LogP | 3.77 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.692 |
Storage condition | -20℃ |
Verinurad |
2-{[3-(4-Cyano-1-naphthyl)-4-pyridinyl]sulfanyl}-2-methylpropanoic acid |
RDEA3170 |
UNII:12WJ62D047 |
Propanoic acid, 2-[[3-(4-cyano-1-naphthalenyl)-4-pyridinyl]thio]-2-methyl- |